News Room

Huntington's Disease, Investor Announcement

Prana Biotechnology Investor Presentation and Audio Recording - Phase 2 HD trial

Prana Investor Presentation and Audio Recording

FEBRUARY 2014: MELBOURNE, Australia and NEW YORK, USA: Prana Biotechnology (ASX:PBT / NASDAQ:PRAN) this morning delivered a presentation for investors regarding the results of its Phase 2 clinical trial of PBT2 in patients with Huntington's disease.

The full presentation, including audio, can be viewed here.

The slide deck can be viewed here